Who owns ESPERION THERAPEUTICS INC NE?
- CUSIP Number: 29664wab1
Tip: Access positions for across all investors
Analyze quarterly positions in Esperion Therapeutics Inc Ne with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Esperion Therapeutics Inc Ne stock
Who bought or sold ESPERION THERAPEUTICS INC NE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| PenderFund Capital Management | 40M | $47M | -1% | Mar 2024 |
|
| Davidson Kempner Capital Management | 30M | $25M | -9% | Mar 2024 |
|
| Pentwater Capital Management | 27M | $22M | -21% | Mar 2024 |
|
| Two Seas Capital | 20M | $17M | 18% | Mar 2024 |
|
| Tenor Capital Management | 19M | $16B | 0% | Mar 2024 |
|
| Highbridge Capital Management | 19M | $15B | -17% | Mar 2024 |
|
| Whitebox Advisors | 17M | $14M | 0% | Mar 2024 |
|
| Ameriprise Financial | 11M | $9.0M | -22% | Mar 2024 |
|
| Readystate Asset Management | 5.5M | $4.6M | 0% | Mar 2024 |
|
| Point72 Asset Management | 5.0M | $4.2M | 11% | Mar 2024 |
|
| Whitefort Capital Management | 4.0M | $3.3M | -18% | Mar 2024 |
|
| Agf Management | 3.8M | $3.1M | 100% | Mar 2024 |
|
| DCF Advisers | 2.8M | $2.3M | -8% | Mar 2024 |
|
| BlackRock | 2.0M | $1.7M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 1.5M | $1.3M | -40% | Mar 2024 |
|
| Ingalls & Snyder | 883k | $733k | -5% | Mar 2024 |
|
| Context Capital Management | 38k | $32M | -100% | Mar 2024 |
|
Who sold out of Esperion Therapeutics Inc Ne?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Silverback Asset Management | Sep 2023 | 6.5M | $3.4B |
| HN Saltoro Capital | Dec 2023 | 1.0M | $593k |
| Morgan Stanley | Sep 2023 | 788k | $406k |